Company intelligence / Profile preview
ConfometRx
Santa Clara, California, United Statesconfometrx.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
ConfometRx specializes in the structural characterization of G-protein coupled receptors to enable structure-based drug discovery. The company has advanced several small-molecule candidates targeting previously intractable GPCRs into lead optimization and preclinical development across multiple therapeutic areas. It collaborates with pharmaceutical partners but has not publicly disclosed clinical results or late-stage assets.
- Therapeutic areas
- PulmonologyMetabolic DisordersOncologyImmunologyPsychiatryCardiovascularNeurology
- Modalities
- Small moleculeprotein engineeringstructure-based drug discovery
- Industry
- Biotech
02
Drug pipeline
6 assets5 more assets in the full pipeline.
03
Partnerships
Collaborations with several pharmaceutical partners for drug discovery programs
Beyond the preview
Go deeper on ConfometRx.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ConfometRx.